NCT02753894View on ClinicalTrials.gov

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Interventions
DRUG

ASP1585

Oral

Trial Locations (11)

Unknown

Site JP00011, Okazaki

Site JP00009, Chiba

Site JP00010, Chiba

Site JP00006, Ibaraki

Site JP00007, Ibaraki

Site JP00008, Ibaraki

Site JP00001, Miyagi

Site JP00002, Miyagi

Site JP00003, Nagano

Site JP00004, Nagano

Site JP00005, Nagano

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY